Last reviewed · How we verify
IPACK and multi-modal analgesic regimen — Competitive Intelligence Brief
marketed
Pain Management / Anesthesia
Small molecule
Live · refreshed every 30 min
Target snapshot
IPACK and multi-modal analgesic regimen (IPACK and multi-modal analgesic regimen) — University Health Network, Toronto. IPACK (Interscalene block, Pecs block, Axillary block, and Knee block) combined with multi-modal analgesia delivers regional anesthesia and systemic pain relief to reduce postoperative pain and opioid consumption.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| IPACK and multi-modal analgesic regimen TARGET | IPACK and multi-modal analgesic regimen | University Health Network, Toronto | marketed |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- IPACK and multi-modal analgesic regimen CI watch — RSS
- IPACK and multi-modal analgesic regimen CI watch — Atom
- IPACK and multi-modal analgesic regimen CI watch — JSON
- IPACK and multi-modal analgesic regimen alone — RSS
Cite this brief
Drug Landscape (2026). IPACK and multi-modal analgesic regimen — Competitive Intelligence Brief. https://druglandscape.com/ci/ipack-and-multi-modal-analgesic-regimen. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab